Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen

Evaluation of aerosol drug delivery with concurrent low- and high-flow nasal oxygen

Question addressed by study Administration of aerosol to patients receiving high-flow nasal oxygen (HFNO) ranges from concurrent aerosol delivery by mouthpiece to aerosol via cannula alone. This study examines the conditions to provide optimal aerosol delivery with low- or high-flow nasal oxygen wit...

Full description

Bibliographic Details
Main Authors:	Barry Murphy, Marc Mac Giolla Eain, Mary Joyce, James B. Fink, Ronan MacLoughlin
Format:	Article
Language:	English
Published:	European Respiratory Society 2022-10-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/8/4/00220-2022.full

Similar Items

The Impact of Head Model Choice on the In Vitro Evaluation of Aerosol Drug Delivery
by: Lauren Gallagher, et al.
Published: (2021-12-01)

In-Line Aerosol Therapy via Nasal Cannula during Adult and Paediatric Normal, Obstructive, and Restrictive Breathing
by: Marc Mac Giolla Eain, et al.
Published: (2023-11-01)

An in vitro visual study of fugitive aerosols released during aerosol therapy to an invasively ventilated simulated patient
by: Marc Mac Giolla Eain, et al.
Published: (2021-01-01)

An in vitro study of the effects of respiratory circuit setup and parameters on aerosol delivery during mechanical ventilation
by: Leanne Reilly, et al.
Published: (2024-01-01)

Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy
by: Gavin Bennett, et al.
Published: (2019-04-01)

Evaluation of Aerosol Drug Delivery Options during Adult Mechanical Ventilation in the COVID-19 Era
by: Piers J. Naughton, et al.
Published: (2021-09-01)

Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control
by: Marc Mac Giolla Eain, et al.
Published: (2022-12-01)

In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
by: Gavin Bennett, et al.
Published: (2019-02-01)

A narrative review on trans-nasal pulmonary aerosol delivery
by: Jie Li, et al.
Published: (2020-08-01)

In vitro model for investigating aerosol dispersion in a simulated COVID-19 patient during high-flow nasal cannula treatment
by: James A. McGrath, et al.
Published: (2022-12-01)

In Vitro Determination of the Main Effects in the Design of High-Flow Nasal Therapy Systems with Respect to Aerosol Performance
by: Gavin Bennett, et al.
Published: (2018-06-01)

State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
by: Hosanna Brave, et al.
Published: (2020-09-01)

Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
by: Niamh Woods, et al.
Published: (2020-09-01)

Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
by: Mary Joyce, et al.
Published: (2021-02-01)

Distribution of Droplets and Immune Responses After Aerosol and Intra-Nasal Delivery of Influenza Virus to the Respiratory Tract of Pigs
by: Veronica Martini, et al.
Published: (2020-10-01)

Evaluation of Aerosol Therapy during the Escalation of Care in a Model of Adult Cystic Fibrosis
by: Elena Fernández Fernández, et al.
Published: (2021-04-01)

Editorial: Advanced therapeutic delivery for the management of chronic respiratory diseases
by: Keshav Raj Paudel, et al.
Published: (2022-08-01)

Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy
by: James A. McGrath, et al.
Published: (2019-06-01)

Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
by: James A. McGrath, et al.
Published: (2019-02-01)

Molecular Insight into the Therapeutic Effects of Stem Cell-Derived Exosomes in Respiratory Diseases and the Potential for Pulmonary Delivery
by: Mohammad H. Azhdari, et al.
Published: (2022-06-01)

Micelle-based nanoparticles with stimuli-responsive properties for drug delivery
by: Maboudi Amir Hosein, et al.
Published: (2024-03-01)

The Ratio of Nasal Cannula Gas Flow to Patient Inspiratory Flow on Trans-nasal Pulmonary Aerosol Delivery for Adults: An in Vitro Study
by: Jie Li, et al.
Published: (2019-05-01)

Aerosol drug delivery to the lungs during nasal high flow therapy: an in vitro study
by: Martin Wallin, et al.
Published: (2019-02-01)

Cellular Immunotherapy and the Lung
by: Sorcha Daly, et al.
Published: (2021-09-01)

In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
by: Alan J. Hibbitts, et al.
Published: (2020-06-01)

Cellular Therapy for the Treatment of Paediatric Respiratory Disease
by: Laura C. Brennan, et al.
Published: (2021-08-01)

Acoustic Aerosol Delivery: Assessing of Various Nasal Delivery Techniques and Medical Devices on Intrasinus Drug Deposition
by: Lara Leclerc, et al.
Published: (2023-01-01)

Magnetic core-shell nanoparticles for drug delivery by nebulization
by: Verma Navin Kumar, et al.
Published: (2013-01-01)

In Vitro Evaluation of Nasal Aerosol Depositions: An Insight for Direct Nose to Brain Drug Delivery
by: Aida Maaz, et al.
Published: (2021-07-01)

Airborne particle dispersion by high flow nasal oxygen: An experimental and CFD analysis.
by: Caroline Crowley, et al.
Published: (2022-01-01)

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
by: Wafaa Alabsi, et al.
Published: (2022-09-01)

In vitro comparison between inspiration synchronized and continuous vibrating mesh nebulizer during trans-nasal aerosol delivery
by: Jie Li, et al.
Published: (2020-01-01)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
by: Éanna Forde, et al.
Published: (2019-05-01)

Clinical studies with high flow nasal cannula oxygen delivery in 2015
by: David Sotello, et al.
Published: (2016-04-01)

Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects
by: Thomas Sécher, et al.
Published: (2022-03-01)

Aerosol delivery through high-flow nasal therapy: Technical issues and clinical benefits
by: Cecilia Calabrese, et al.
Published: (2023-01-01)

Effects of flow rate on transnasal pulmonary aerosol delivery of bronchodilators via high-flow nasal cannula for patients with COPD and asthma: protocol for a randomised controlled trial
by: Jian Luo, et al.
Published: (2019-06-01)

Nasal implants for drug delivery: Advancements and applications
by: Hiti, et al.
Published: (2023-12-01)

In Vitro Anatomical Models for Nasal Drug Delivery
by: Gerallt Williams, et al.
Published: (2022-06-01)

Nasal Delivery of High Molecular Weight Drugs
by: Erdal Cevher, et al.
Published: (2009-09-01)